Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank86
5Y CAGR-17.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-17.8%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$21.70M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$57.72M+3118.9%
2019$1.79M+373.1%
2018$379000.00-